Postherpetic Neuralgia

POSTHERPETIC NEURALGIA

Feature Article

Overdoses Related to Heroin Tripled in Three-Year Period

Compliance Key to Managing Postherpetic Neuralgia

Beth Gilbert, Pat F. Bass III, MD, MS, MPH

January 14, 2015

Treating this neuropathic pain condition can be complicated because of polypharmacy, drug dosing schedules, adverse events, drug-drug interactions, and patient comorbidities.

Latest

Effect of Low-Level Laser Therapy on Incidence of Postherpetic Neuralgia

Alicia Ciccone, Digital Content Editor

Because the increased cytokine levels in the acute phase of herpes zoster are assumed to be a potential mechanism for inducing PHN, the early suppression of these cytokines by LLLT may help prevent the development of PHN.

Is Asthma Linked to Shingles Risk in Adults?

Odds of herpes zoster 70% higher among people with respiratory condition.

Herpes Zoster Vaccine Not Cost-Effective in Adults Aged 50 Years, Study Shows

At willingness-to-pay threshold of 100,000 per QALY, 3 probability of vaccine being cost-effective.

Pregabalin: An Overview

A new analysis pooled patient-level data from 31 randomized, placebo-controlled studies of pregabalin in peripheral NeP.

Neck Study Findings Contradict Recommendations

PHN Therapy Efficacious in Phase 3 Study

Mital Patel, PharmD

Pfizer announced results from a phase-3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (PHN).

PHN Study Confirms Importance of Vaccination

New research highlights the incidence of postherpetic neuralgia (PHN) and its significant burden of disease among elderly patients over time.